2-isopropyl-6-methyl-piperazine | 19830-88-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 2-isopropyl-6-methyl-piperazine
• 英文别名: 2-Methyl-6-propan-2-ylpiperazine
• CAS: 19830-88-7
• 化学式: C₈H₁₈N₂
• mdl: MFCD18072979
• 分子量: 142.244
• InChiKey: JDSBAPARLMHKAJ-UHFFFAOYSA-N

物化性质

• 沸点：
  95-97 °C(Press: 22 Torr)
• 密度：
  0.833±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  24.1
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• [EN] ANTIMICROBIALS AND METHODS OF MAKING AND USING SAME<br/>[FR] ANTIMICROBIENS ET LEURS PROCÉDÉS DE PRÉPARATION ET D'UTILISATION
  申请人：MELINTA THERAPEUTICS INC

  公开号：WO2017193023A1

  公开（公告）日：2017-11-09

  The present disclosure relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, reducing the risk of, and delaying the onset of microbial infections in humans and animals. In some embodiments, the present disclosure provides a compound of Formula (I): or a tautomer thereof or a pharmaceutically acceptable salt of the compound or tautomer.

  本公开涉及抗微生物化合物领域以及制备和使用这些化合物的方法。这些化合物对于治疗、预防、减少人类和动物微生物感染的风险以及延缓微生物感染的发生都是有用的。在某些实施例中，本公开提供一种化合物的化学式(I)：或其互变异构体或该化合物或互变异构体的药用可接受盐。
• Macrocyclic kinase inhibitors and uses thereof
  申请人：Dana-Farber Cancer Institute, Inc.

  公开号：US10457691B2

  公开（公告）日：2019-10-29

  The present disclosure provides macrocyclic compounds of Formula (I). The provided compounds are able to bind protein kinases and may be useful in modulating (e.g., inhibiting) the activity of a protein kinase in a subject or cell and/or in treating or preventing a disease (e.g., proliferative disease, genetic disease, hematological disease, neurological disease, painful condition, psychiatric disorder, or metabolic disorder) in a subject in need thereof. Also provided are pharmaceutical compositions, kits, methods, and uses that include or involve a compound described herein.

  本公开提供了式(I)的大环化合物。所提供的化合物能够与蛋白激酶结合，可用于调节（如抑制）受试者或细胞中蛋白激酶的活性，和/或治疗或预防有需要的受试者的疾病（如增殖性疾病、遗传性疾病、血液病、神经性疾病、疼痛性疾病、精神疾病或代谢性疾病）。还提供了包括或涉及本文所述化合物的药物组合物、试剂盒、方法和用途。
• Chromium-mediated coupling and application to the synthesis of halichondrins
  申请人：President and Fellows of Harvard College

  公开号：US10633392B2

  公开（公告）日：2020-04-28

  The present invention provides unified synthesis of the CI-CI 9 building blocks of halichondrins and analogs thereof using selective coupling of poly-halogenated nucleophiles in chromium-mediated coupling reactions. The present invention also provides a practical and efficient synthesis of C20-C38 building blocks of halichondrins and analogs thereof. Also provided herein are general methods of selective activation and coupling of poly-halogenated analogs with an aldehyde. The provided coupling reactions are selective for halo-enone and halo-acetylenic ketal over vinyl halide and halide attached to a sp hydridized carbon. The provided efficient selective coupling reactions can allow easy access to the CI-CI 9 building blocks and C20-C38 building blocks of halichondrins and analogs thereof with limited or no purification or separation of the intermediates.

  本发明提供了在铬介导的偶联反应中利用多卤代亲核物的选择性偶联来统一合成卤代姜黄素及其类似物的 CI-CI 9 结构单元。本发明还提供了一种实用高效的卤代龙毒素及其类似物的 C20-C38 结构单元的合成方法。本发明还提供了选择性活化多卤代类似物并将其与醛偶联的一般方法。所提供的偶联反应对卤代烯酮和卤代乙炔缩酮具有选择性，而对乙烯基卤化物和连接到 sp 水化物碳上的卤化物则没有选择性。所提供的高效选择性偶联反应可以方便地获得卤代烯酮及其类似物的 CI-CI 9 结构单元和 C20-C38 结构单元，中间产物的纯化或分离程度有限或根本不需要。
• Therapeutic compounds and uses thereof
  申请人：Kala Pharmaceuticals, Inc.

  公开号：US10758539B2

  公开（公告）日：2020-09-01

  Described herein are compounds of Formula (I)-(III), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Also provided are particles (e.g., nanoparticles) comprising compounds of Formula (I)-(III) and pharmaceutical compositions thereof that are mucus penetrating. Methods of using the compounds or pharmaceutical compositions thereof for treating and/or preventing diseases are also provided.

  本文描述了式 (I)-(III) 化合物、其药学上可接受的盐及其药物组合物。还提供了由式（I）-（III）化合物及其药物组合物组成的具有粘液渗透性的颗粒（如纳米颗粒）。还提供了使用这些化合物或其药物组合物治疗和/或预防疾病的方法。
• Antimicrobials and methods of making and using same
  申请人：BIOVERSYS AG

  公开号：US10934295B2

  公开（公告）日：2021-03-02

  The present disclosure relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, reducing the risk of, and delaying the onset of microbial infections in humans and animals. In some embodiments, the present disclosure provides a compound of Formula (I): or a tautomer thereof or a pharmaceutically acceptable salt of the compound or tautomer.

  本公开内容一般涉及抗微生物化合物领域及其制造和使用方法。这些化合物可用于治疗、预防、降低人和动物微生物感染的风险并延缓其发生。在一些实施方案中，本公开提供了式(I)化合物：或其同系物或该化合物或同系物的药学上可接受的盐。